27 March 2019

Meningitis is the most deadly manifestation of tuberculosis. Following a series of smaller trials that showed a benefit of high-dose rifampicin for tuberculous meningitis, Reinout van Crevel (Dept of Internal Medicine) and Rob Aarnoutse, Lindsey te Brake and Elin Svensson (Dept of Pharmacy/Pharmacology), theme Infectious diseases and global health, have received funding (4 million British Pounds) from the MRC Wellcome Trust global health trials scheme for a phase 3 randomized clinical trial evaluating high-dose rifampicin in 500 tuberculous meningitis patients in Indonesia, Uganda and South Africa.

Besides intensified antibiotic treatment, targeting damaging inflammation might also improve survival of tuberculous meningitis patients. Following the discovery of a critical role for cerebral tryptophan metabolism (Van Laarhoven et al, Lancet Inf Dis 2018), Van Crevel and colleagues Arjan van Laarhoven, Vinod Kumar and Mihai Netea from the department of Internal Medicine, theme Infectious diseases and global health, have also received 5-year funding (4 million Euro) from the National Institute of Health (NIH, Washington) to apply a ‘multi-omics’ approach in >2000 tuberculous meningitis patients from Vietnam and Indonesia, aiming to find more effective host-directed therapy with collaborators from Boston, Vietnam and Indonesia. 
 

Related news items


ERC Consolidator Grant for Bousema and Sechopoulos

12 December 2019

Teun Bousema and Ioannis Sechopoulos are to receive an ERC Consolidator Grant of around two million euros each. This European research subsidy will enable them to carry out research for the next five years.

read more

New insights into the initiation of T cell responses in the spleen

11 December 2019

Carl Figdor and colleagues, theme Cancer development and immune defense, provide insights into the initiation of T cell responses in the spleen and their consequences for T cell differentiation. They have published their results in Proceedings of the National Academy of Sciences USA.

read more

A personal touch of Marieke Willemse

10 December 2019

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Marieke Willemse.

read more

Two teams of RIMLS-FNWI participate in Alpe d'HuZes

10 December 2019

Sixteen employees of the research institute RIMLS-FNWI have taken on the challenge to run, bike or hike up the mountain Alpe d’Huez as many times as possible 4 June 2020, to raise as much money as possible for cancer research.

read more

Dietrich-Knorr Prize for Hedi Claahsen-van der Grinten

10 December 2019

Hedi Claahsen-van der Grinten, theme Vascular damage, received the Dietrich-Knorr prize 2019 for the best published paper in the field of adrenal research, for her publication in the Journal of Clinical endocrinology & Metabolism.

read more

Help wanted to organize the New Frontiers symposium in 2021

9 December 2019

Are you a 1st or 2nd year PhD candidate with the ambition to organize an international symposium? The organizing committee of the RIMLS New Frontiers Symposium in 2021 dedicated to Glycobiology is looking for two PhD candidates who are interested to participate in the organization.

read more